Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer,Int J Cancer,2021.148: 941-9

BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients,Int J Cancer,2020. 146: 3044-52

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer,Int J Cancer,2020.146(2):487-495

Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program,Molecular cell,2018. 71(4):526-539.e8

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients,Clin Cancer Res,2017. 23(20):6113-6119

家族遗传性乳腺癌

中国人群特异BRCA1/2重复突变的乳腺癌发病风险评估及功能研究, 课题负责人, 2017.1.1～2020.12.31, 国家自然科学基金面上项目

DNA修复基因致病性突变对乳腺癌新辅助化疗疗效的预测作用, 课题负责人, 2021.1.1～2023.12.31, 北京市医管局培育项目

中国家族性乳腺癌BRCA1/2基因大片段重排断裂位点鉴定及功能研究, 参加者, 2018.1.1～2021.12.31, 国家自然科学基金面上项目

乳腺癌个体化治疗的临床与基础研究, 参加者, 2014.1.1～2017.12.31, 科技部